Here are three things to know:
1. Mr. Cook has more than 25 years of experience. He led the asset purchase of International Biologics, renamed Lattice Biologics, in September 2013.
2. He founded and developed Bacterin International from a small contract research and development startup to a publicly-traded multinational organization with sales in over 15 countries, a multimillion dollar revenue and more than 150 employees.
3. Mr. Cook spent more 18 years in the tissue engineering field, beginning his career as a confocal microscopist scientist.
More articles on biologics:
Cellect receives patent approval for Apograft technology: 3 notes
OsteoRemedies unveils 1st FDA-cleared dual-antibiotic spacer & bone cement: 3 notes
MTF Biologics & Academy Medical join forces to bring allografts to the VA: 4 notes
